Creating a market access strategy for Zulresso® /

Sage Therapeutics is a neuroscience-focused biopharmaceutical company founded in Cambridge, Massachusetts, in 2010. Their primary focus is on introducing innovative therapies and solutions for brain disorders. Zulresso®, Sage's only marketed product as of 2022, received its FDA approval under p...

Full description

Bibliographic Details

Main Authors:	Dasgupta, Swikriti (Author), Sharma, Taijasi (Author), Munshaw, Supriya (Author)
Format:	eBook
Language:	English
Published:	London : SAGE Publications: SAGE Business Cases Originals, 2023.
Series:	Sage business cases.
Subjects:	New products > Case studies. Business planning > Case studies. Business planning New products Electronic books. Case studies
Online Access:	Connect to the full text of this electronic book